Skip to content

Dr. SOFIE JAMAR

Active
Private limited companyfounded 2007active for 18 yearsGrote Doelstraat 6, 2820 Bonheiden, BelgiumKBO/BCE: BE 0894.438.582
Summary

Dr. SOFIE JAMAR has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €487,853 and a net result of €123,668. Equity is growing by about 19% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
“De uitoefening van de geneeskunde met specialisatie inwendige ziekten en nierziekten,met inachtneming van de…” (deed in Dutch)
From the articles, 17 activitiesNo NACE code in the KBO yet1 site
Size
≈ €560,000turnover 2025, estimated
Equity
€487,853
Profit
€123,668
Turnover estimated from the gross margin
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
2025 accounts 93 days early1 of 3 deeds summarised
Why 95lowers riskSize: total assets €517,303Equity €487,853 (94.3% of total assets)Figures for financial year 2025 (filed 30-04-2026)Founded in 2007Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 58% of its sector peers (no NACE code, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 94.3% of total assets
Liquidity 61-13
short-term debt 5.5% · cash 8.8%
Profitability 99+5
return on assets 23.9%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: 0.1%▲ +0.1 percentage points vs 05-2026highest value 07-2026: 0.1%● unchanged vs 06-2026highest value 08-2026: 0.1%● unchanged vs 07-2026highest value 09-2026: 0.1%● unchanged vs 08-2026highest value 10-2026: 0.1%● unchanged vs 09-2026highest value
Credit of up to €45,000 on 30-day terms is acceptable
Liquidity ample (current ratio 13.22, compared with 35.34 in 2024, above the usual 1.5; short-term debt: 5.5% and cash: 8.8% of total assets), and 5.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 58% on liquidity, 78% on profitability and 16% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Size: total assets €517,303
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €487,853 (94.3% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 30-04-2026)
NBB · annual accounts
lowers risk · Founded in 2007
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-04-2026, 93 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
93 days early
2024
93 days early
2023
98 days early
2022
150 days early
2021
72 days early
2020
162 days early
2019
35 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 100 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 April (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Highest result from 2018 to 2025net €131,899 ▲11.2%

Financials · financial year 2025, micro format

Turnover
≈ €560,000
Estimated: probably between €370,000 and €860,000
Total assets
€517,303▼ 20.1%
2024 · €647,586
Net result
€123,668▼ 6.2%
2024 · €131,899
Working capital
€344,667▼ 28.8%
2024 · €483,842
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result falls in 2025; 2025 is 4% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€176,491 2025 Net result€123,668 2025

Use the arrow keys on the chart for the figures per year.

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€108,797-€121,090▲ 11.3%€142,764▲ 17.9%€123,785▼ 13.3%€141,763▲ 14.5%€167,068▲ 17.9%€183,508▲ 9.8%€176,491▼ 3.8%
Net result€75,157-€81,643▲ 8.6%€99,708▲ 22.1%€87,961▼ 11.8%€99,431▲ 13.0%€118,595▲ 19.3%€131,899▲ 11.2%€123,668▼ 6.2%
Equity€224,650-€248,070▲ 10.4%€347,778▲ 40.2%€373,515▲ 7.4%€460,884▲ 23.4%€579,480▲ 25.7%€633,497▲ 9.3%€487,853▼ 23.0%
Total assets€263,202-€278,351▲ 5.8%€379,148▲ 36.2%€386,500▲ 1.9%€479,958▲ 24.2%€592,703▲ 23.5%€647,586▲ 9.3%€517,303▼ 20.1%
Debt€38,553-€30,282▼ 21.5%€31,370▲ 3.6%€12,985▼ 58.6%€19,073▲ 46.9%€13,224▼ 30.7%€14,089▲ 6.5%€29,450▲ 109%
Working capital€162,475-€201,741▲ 24.2%€208,536▲ 3.4%€204,231▼ 2.1%€331,169▲ 62.2%€485,443▲ 46.6%€483,842▼ 0.3%€344,667▼ 28.8%
Turnover and EBIT margin not published: the micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €517,303
Fixed assets €144,433 ▼ 3.5%
Current assets €372,870 ▼ 25.1%
Equity and liabilities €517,303
Equity €487,853 ▼ 23.0%
Debt €29,450 ▲ 109%
Debt's share of the balance-sheet total rises from 2.2% to 5.7%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€222,276▲
2024 · €219,600
Cash flow
€169,453▲
2024 · €167,992
Current ratio
13.22▼
2024 · 35.34
Debt to equity
0.06▲
2024 · 0.02
ROE
25.3%▲
2024 · 20.8%
ROA
23.9%▲
2024 · 20.4%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€28,203▲
2024 · €14,089
Income taxes
€55,412▼
2024 · €57,729
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 17,811 companies that looked in July 2024 the way this one looks now, 0.3% went bankrupt within 24 months and 96.5% are still going.

  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.3% went bankrupt
3.2% stopped otherwise
96.5% still going

For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 17,811 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet Code20242025
Assets
Total assets20/58€647,586€517,303▼
Fixed assets21/28€149,655€144,433▼
Tangible fixed assets22/27€149,655€144,433▼
Land and buildings22€16,568€30,273▲
Plant, machinery and equipment23€23,254€22,604▼
Furniture and vehicles24€109,834€91,556▼
Current assets29/58€497,931€372,870▼
Amounts receivable after more than one year29€260,000€100,000▼
Other amounts receivable291€260,000€100,000▼
Amounts receivable within one year40/41€4,774€6,311▲
Trade receivables40€4,774€3,150▼
Other amounts receivable41-€3,160
Current investments50/53€99,617€199,732▲
Cash at bank and in hand54/58€124,788€45,375▼
Deferred charges and accrued income490/1€8,753€21,452▲
Equity and liabilities
Total equity and liabilities10/49€647,586€517,303▼
Equity10/15€633,497€487,853▼
Contributions10/11€12,400€12,400=
Reserves13€621,097€475,453▼
Distributable reserves133€621,097€475,453▼
Amounts payable17/49€14,089€29,450▲
Amounts payable within one year42/48€14,089€28,203▲
Trade debts44€8,265€20,255▲
Suppliers440/4€8,265€20,255▲
Taxes, remuneration and social security45€5,409€7,948▲
Taxes450/3€4,509€7,048▲
Remuneration and social security454/9€900€900=
Other amounts payable47/48€415-
Accrued charges and deferred income492/3-€1,246
Income statement Code20242025
Non-recurring operating income76A€734€757▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€36,093€45,785▲
Other operating charges640/8€875€940▲
Gross operating margin9900€220,475€223,216▲
Operating profit (loss)9901€183,508€176,491▼
Financial income75/76B€6,179€3,507▼
Recurring financial income75€6,179€3,507▼
Financial charges65/66B€58€918▲
Recurring financial charges65€58€918▲
Profit (loss) for the period before taxes9903€189,628€179,080▼
Income taxes67/77€57,729€55,412▼
Profit (loss) for the period9904€131,899€123,668▼
Profit (loss) for the period to be appropriated9905€131,899€123,668▼
Appropriation of the result
Profit (loss) to be appropriated9906€131,899€123,668▼
Transfer from equity791/2€77,882€269,312▲
Transfer to equity691/2€131,899€123,668▼
To other reserves6921€131,899€123,668▼
Profit to be distributed694/7€77,882€269,312▲
Return on contributions (dividend)694€77,882€269,312▲

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Non-recurring operating income76A---€641€646€1,737€734€757▲ 3.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€32,278€34,889€18,938€43,435€47,353€43,129€36,093€45,785▲ 26.9%
Other operating charges640/8---€1,147€804€1,031€875€940▲ 7.4%
Gross operating margin9900€142,288€157,788€162,858€168,368€189,920€211,227€220,475€223,216▲ 1.2%
Operating profit (loss)9901€108,797€121,090€142,764€123,785€141,763€167,068€183,508€176,491▼ 3.8%
Financial income75/76B---€36€875€3,823€6,179€3,507▼ 43.2%
Recurring financial income75€110€11-€36€875€3,823€6,179€3,507▼ 43.2%
Financial charges65/66B---€45€79€48€58€918▲ 16×
Recurring financial charges65€1,089€234€64€45€79€48€58€918▲ 16×
Profit (loss) for the period before taxes9903€107,818€120,867€142,700€123,777€142,559€170,842€189,628€179,080▼ 5.6%
Income taxes67/77€32,661€39,224€42,992€35,815€43,128€52,247€57,729€55,412▼ 4.0%
Profit (loss) for the period9904€75,157€81,643€99,708€87,961€99,431€118,595€131,899€123,668▼ 6.2%
Profit (loss) for the period to be appropriated9905€75,157€81,643€99,708€87,961€99,431€118,595€131,899€123,668▼ 6.2%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€263,202€278,351€379,148€386,500€479,958€592,703€647,586€517,303▼ 20.1%
Fixed assets21/28€65,352€46,328€139,241€169,283€129,715€94,036€149,655€144,433▼ 3.5%
Tangible fixed assets22/27€65,352€46,328€139,241€169,283€129,715€94,036€149,655€144,433▼ 3.5%
Land and buildings22---€25,412€22,464€19,516€16,568€30,273▲ 82.7%
Plant, machinery and equipment23---€9,124€11,132€11,672€23,254€22,604▼ 2.8%
Furniture and vehicles24---€134,747€96,119€62,849€109,834€91,556▼ 16.6%
Current assets29/58€197,850€232,023€239,907€217,217€350,242€498,667€497,931€372,870▼ 25.1%
Amounts receivable after more than one year29----€140,000€260,000€260,000€100,000▼ 61.5%
Other amounts receivable291----€140,000€260,000€260,000€100,000▼ 61.5%
Amounts receivable within one year40/41€28,664€30,607€19,714€35,290€33,488€4,454€4,774€6,311▲ 32.2%
Trade receivables40---€31,105€33,488€4,454€4,774€3,150▼ 34.0%
Other amounts receivable41---€4,185---€3,160-
Current investments50/53------€99,617€199,732▲ 101%
Cash at bank and in hand54/58€169,187€199,014€217,772€181,474€173,268€229,929€124,788€45,375▼ 63.6%
Deferred charges and accrued income490/1---€452€3,487€4,284€8,753€21,452▲ 145%
Equity and liabilities
Total equity and liabilities10/49€263,202€278,351€379,148€386,500€479,958€592,703€647,586€517,303▼ 20.1%
Equity10/15€224,650€248,070€347,778€373,515€460,884€579,480€633,497€487,853▼ 23.0%
Contributions10/11€12,400€12,400-€12,400€12,400€12,400€12,400€12,400=
Reserves13€212,250€235,670€335,378€361,115€448,484€567,080€621,097€475,453▼ 23.4%
Non-distributable reserves130/1---€1,860€1,860----
Reserves not available under the articles1311---€1,860€1,860----
Distributable reserves133---€359,255€446,624€567,080€621,097€475,453▼ 23.4%
Amounts payable17/49€38,553€30,282€31,370€12,985€19,073€13,224€14,089€29,450▲ 109%
Amounts payable after more than one year17€3,177--------
Amounts payable within one year42/48€35,375€30,282€31,370€12,985€19,073€13,224€14,089€28,203▲ 100%
Trade debts44€12,305€16,745€12,017€10,761€13,721€5,864€8,265€20,255▲ 145%
Suppliers440/4---€10,761€13,721€5,864€8,265€20,255▲ 145%
Taxes, remuneration and social security45---€900€4,028€6,275€5,409€7,948▲ 46.9%
Taxes450/3----€3,128€5,375€4,509€7,048▲ 56.3%
Remuneration and social security454/9---€900€900€900€900€900=
Other amounts payable47/48---€1,324€1,324€1,085€415--
Accrued charges and deferred income492/3-------€1,246-
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€75,157€81,643€99,708€87,961€99,431€118,595€131,899€123,668▼ 6.2%
+ Depreciation and write-downs630€32,278€34,889€18,938€43,435€47,353€43,129€36,093€45,785▲ 26.9%
Operating cash flow (approximation)€107,435€116,532€118,646€131,396€146,784€161,724€167,992€169,453▲ 0.9%
Investment in fixed assets (approximation)--€15,866-€111,851-€73,477-€7,785-€7,450-€91,712-€40,563▲ 55.8%
Change in cash-€29,827€18,758-€36,298-€8,207€56,661-€105,141-€79,413▲ 24.5%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 18 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 micro format 29-04-2026 2026-00095613
31-12-2024 micro format 29-04-2025 2025-00079180
31-12-2023 micro format 24-04-2024 2024-00067519
31-12-2022 micro format 03-03-2023 2023-00034819
31-12-2021 micro format 20-05-2022 2022-20032580
31-12-2020 micro format 19-02-2021 2021-05700276
31-12-2019 micro format 26-06-2020 2020-21900005
31-12-2018 micro format 22-06-2019 2019-21800455
31-12-2017 micro format 12-06-2018 2018-17900057
31-12-2016 micro format 26-06-2017 2017-21500109

Show all 18 filings

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
2 directors, last change in 2023
JAMAR Sofie Ann
Director (not named in the articles)
Current
PERSOONS Steven Julienne Paul
Director (not named in the articles)
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
2 of this company's 3 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

2 people since 2023, 2 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
JAMAR Sofie Ann
  • Manager, until 21-11-2023
  • Director (not named in the articles), since before 21-11-2023
PERSOONS Steven Julienne Paul
  • Manager, until 21-11-2023
  • Director (not named in the articles), since before 21-11-2023
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Capital over the years
  1. 21-11-2023 Converted to unavailable equity

Group and network

Connections & network

2 current directors
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

Dr. SOFIE JAMAR was incorporated on 20 December 2007.1 Total assets rose from €263,202 in 2018 to €517,303 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
29-04
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
29-04
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Highest result from 2018 to 2025net €131,899 ▲11.2%
Operating result €183,508, net result €131,899, both a record.
24-04
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Liquidity more than doubledcurrent ratio 37.71
Current ratio from 18.36 to 37.71; short-term debt falls from €19,073 to €13,224.
31-12
Financial Equity above €500,000equity €579,480 ▲25.7%
A profit in every financial year since 2018 builds equity to €579,480.
21-11
Gazette deed Resignations: JAMAR Sofie Ann (manager) and PERSOONS Steven Julienne Paul (manager)
Reappointments: JAMAR Sofie Ann (director) and PERSOONS Steven Julienne Paul (director) · Capital · Power of attorney13 facts ▸
  • Capital
  • Director resignation, JAMAR Sofie Ann (manager)
  • Director resignation, PERSOONS Steven Julienne Paul (manager)
  • Director reappointment, JAMAR Sofie Ann (director (not named in the articles))
  • Director reappointment, PERSOONS Steven Julienne Paul (director (not named in the articles))
  • Other provision, “uitoefening mandaat, kwijting aan ontslagnemende zaakvoerders” (deed in Dutch)
  • Power of attorney
  • General meeting, 15-11-2023
  • Other provision, “aanpassing statuten aan WVV en behoud rechtsvorm, statuten aanpassen en rechtsvorm besloten vennootschap behouden” (deed in Dutch)
  • Registered office clause, “Vlaams Gewest, adresverwijzing in statuten” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Reserve release, “opheffen statutair onbeschikbare eigen vermogensrekening en beschikbaar maken voor uitkering, vormen en meerderheden statutenwijziging” (deed in Dutch)
  • +1 further fact in this act
03-03
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
20-05
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Liquidity more than doubledcurrent ratio 16.73
Current ratio from 7.65 to 16.73; short-term debt falls from €31,370 to €12,985.
19-02
NBB filing Annual accounts filed
financial year 2020 · micro format
2020
26-06
NBB filing Annual accounts filed
financial year 2019 · micro format
Show earlier events
2019
22-06
NBB filing Annual accounts filed
financial year 2018 · micro format
2018
12-06
NBB filing Annual accounts filed
financial year 2017 · micro format
2017
26-06
NBB filing Annual accounts filed
financial year 2016 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 18 annual accounts filed, the latest 10 are here; all 18 are under Financials.
1 of 3 deeds read
About the unread acts

Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded20-12-2007
Financial year end31-12
Contact
E-mail steven.persoons@pm.me
E-mail steven.persoons@gmail.comBonheiden
Phone 015/55.96.94Bonheiden
E-invoicing
Reachable via Peppol
Peppol ID 0208:0894438582
Also 9925:BE0894438582
Registered 24-11-2023

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Legal Entity Identifier

699400KPMUWDNEWQW263
live in the LEI register

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Bonheiden · 1 establishment unit since 2007
registered office establishment The establishment unit on the map
Ground area
2,221 m²
Building footprint
402 m²
Building volume
2,207 m³
2 parcels, Flanders · tallest building 11.0 m. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
Grote Doelstraat 6b, 2820 Bonheiden
Specialist medical practice
since 2007unit no. 2.185.613.502
2 parcels
Flanders 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
12005B0315/00R000 Flanders 1,434 m² 1 · 238 m² 6.5 m · 1
12005B0315/00A002 Flanders 787 m² 1 · 164 m² 11.0 m · 2
How the parcels are linked
Good to know
Both parcels match the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“De uitoefening van de geneeskunde met specialisatie inwendige ziekten en nierziekten,met inachtneming van de regels van de medische…” (deed in Dutch)
17 activities (deed in Dutch)
  1. De uitoefening van de geneeskunde met specialisatie inwendige ziekten en nierziekten,met inachtneming van de regels van de medische deontologie.
  2. De aandeelhouder oefent zijn volledige medische activiteit uit in naam en voor rekening van de vennootschap.
  3. Het verstrekken van adviezen en raadgevingen.
  4. De professionele aansprakelijkheid van de arts-aandeelhouder is onbeperkt.
  5. Deze activiteiten worden uitgeoefend met eerbiediging van de deontologische en administratieve voorschriften,volgens de principes van de medische ethiek en de eisen van de wetenschappelijke discipline.Meer bepaald zal de vrije artsenkeuze in hoofde van de patiënt,de diagnostische en therapeutische vrijheid alsook het respect voor het medisch beroepsgeheim behouden blijven.
  6. De vennootschap waakt erover dat de onafhankelijkheid van de aandeelhouder in de uitoefening van zijn beroep gewaarborgd blijft;
  7. Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder,die nodig of nuttig zijn voor de uitoefening van voornoemde activiteiten.
  8. De aankoop,het huren,leasen en invoeren van alle medische apparatuur en begeleidende accommodaties,inclusief gebouwen en transportmiddelen,voor voornoemde activiteiten,kortom van een volledige materiële infrastructuur voor de praktijk van de arts-aandeelhouder.
  9. Het aanleggen van reserves,nodig tot het aanschaffen van alle dienstige apparatuur,gebouwen en transportmiddelen noodzakelijk en bevorderlijk voor het uitoefenen van alle bovenvermelde beroepsactiviteiten door de arts-aandeelhouder.
  10. De mogelijkheid scheppen om de aandeelhouder toe te laten zich verder te bekwamen in voormelde medische disciplines,dit teneinde een kwalitatief hoogstaande praktijkuitoefening mogelijk te maken.
  11. Bovendien kan de vennootschap informatie verstrekken en of onderricht geven,zonder dat dit de vorm van een aanvullende commerciële activiteit mag aannemen.
  12. De vennootschap mag samenwerken met alle ondernemingen die een gelijkaardig voorwerp nastreven,maar overeenkomsten die artsen niet mogen afsluiten met andere artsen of met derden,zullen evenmin door de vennootschap mogen afgesloten worden.
  13. Aldus zal de vennootschap geen deelnemingen mogen bezitten van een andere artsenvennootschap waarbinnen een medische activiteit wordt uitgeoefend.
  14. De vennootschap kan deelnemen in kostenassociaties of middelenvennootschappen van artsen,of lid zijn van een vereniging zonder winstgevend doel van artsen.
  15. De vennootschap mag als bijkomstig voorwerp,beleggen in roerende of onroerende goederen,mits dit een beheren is van de roerende en onroerende goederen als een voorzichtig en redelijk persoon,en zonder dat dit op geen enkel ogenblik aanleiding mag geven tot het ontwikkelen van welke commerciële activiteit ook.
  16. Wanneer er meerdere aandeelhouders zijn,dienen de beslissingen in verband met het investeringsbeleid te gebeuren met unanimiteit van stemmen.
  17. De vennootschap zal in het algemeen alle burgerlijke,roerende of onroerende handelingen mogen verrichten in rechtstreeks verband met haar maatschappelijk voorwerp of welke van die aard zouden zijn dat zij het bereiken ervan rechtstreeks,geheel of ten dele vergemakkelijken,dit alles rekening houdend met de medische deontologie ter zake.

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
DR.SOFIE JAMAR
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaams Gewest, bij enkel besluit bestuursorgaan in België of buitenland” (deed in Dutch)

deed of 21-11-2023

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
“De vennootschap wordt ten overstaan van derden, in en buiten rechte, in alle rechtshandelingen en akten, met inbegrip van die akten die de…”
Board ruleHow the board is made up, meets and takes decisions.
“Één of meerdere bestuurders, niet-statutaire bestuurder ad nutum herroepbaar bij gewone meerderheid” (deed in Dutch)

deed of 21-11-2023

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Register van aandelen op naam, volgnummer” (deed in Dutch)
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Rechten waarvan overdracht wordt voorgesteld, bestuursorgaan” (deed in Dutch)
Share issue ruleHow and by whom new shares can be issued.
“Inbreng in geld met uitgifte van nieuwe aandelen - recht van voorkeur, naar evenredigheid van het aantal aandelen dat zij bezitten” (deed in Dutch)

deed of 21-11-2023

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
First Tuesday of June at 20:00

deed of 21-11-2023

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
One provision in the deed
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
One provision in the deed

deed of 21-11-2023

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Stortingsplicht aandelen, bestuursorgaan” (deed in Dutch)
Other provision: “Bestuurder,bij gebrek aanwezige aandeelhouder met meeste aandelen,bij pariteit oudste, zittingen processen-verbaal” (deed in Dutch)
Other provision: “Verdaging, slechts één keer,tweede vergadering beslist definitief” (deed in Dutch)
Other provision: “Bestemming van de winst, algemene vergadering” (deed in Dutch)
Other provision: “Uitkering van dividenden en interimdividenden, verminderd met overgedragen verlies of vermeerderd met overgedragen winst” (deed in Dutch)
Liquidation distribution: “Aanzuivering schulden,lasten en kosten vereffening of consignatie nodige sommen en herstelling evenwicht tussen niet-volgestorte aandelen…” (deed in Dutch)
Other provision: “Alle mededelingen,aanmaningen,dagvaardingen en betekeningen geldig, woonstkeuze” (deed in Dutch)
Other provision: “Gerechtelijke bevoegdheid, tenzij vennootschap er uitdrukkelijk aan verzaakt” (deed in Dutch)
Other provision: “Gemeen recht, bepalingen Wetboek van vennootschappen en verenigingen waarvan niet geldig zou zijn afgeweken” (deed in Dutch)
Other provision: “Medische deontologie artsen-aandeelhouders, Nationale raad van de Orde der artsen” (deed in Dutch)
Other provision: “Aansprakelijkheid arts-aandeelhouder” (deed in Dutch)
Other provision: “Netting, nettingsovereenkomsten zoals voorzien in wet van 15 december 2004” (deed in Dutch)
4 more provisions in the deed, see the deed of 21-11-2023

deed of 21-11-2023